🔎 Trials Near Me

Home › Eczema › Florida

Eczema clinical trials in Florida

11 studies for Eczema are looking for participants at sites in Florida.

Cities in Florida

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  • Pediatric Skin Research, Miami
  • AllerVie Clinical Research, Panama City
  • GCP Research , Global Clinical Professionals, St. Petersburg
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

  • True Blue Clinical Research, Tampa
RecruitingObservational study
Ages 12 to 89 · All sexes · Updated Nov 9, 2026 · NCT07645820

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

  • Florida International Research Center, Miami
  • Encore Medical Research of Weston LLC, Weston
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07527923

Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis

  • Arcutis Site 321, Miami Lakes
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Nov 6, 2026 · NCT07916480

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  • Direct Helpers Research Center, Hialeah
  • Research Associates of South Florida, LLC, Miami
  • Global Health Research Center, Inc., Miami Lakes
  • and 2 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  • Solutions Through Advanced Research, Jacksonville
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Nov 5, 2026 · NCT06807281

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

  • Gsi Clinical Research, Margate
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Nov 5, 2026 · NCT07216027

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

  • Clinical Site 112, Miami
  • Clinical Site 110, Miami
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Oct 23, 2026 · NCT07453602

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Miami
  • Novartis Investigative Site, St. Petersburg
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • ABMED Clinical Research Corp., Cape Coral
  • Skin Care Research, Hollywood
  • Quality Care Clinical Research, Miami
  • and 4 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 19, Ocala
  • Inmagene Site 4, Tampa
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.